{
    "Trade/Device Name(s)": [
        "Xpert\u00ae HemosIL\u00ae FII & FV Factor II and Factor V Genotyping Assay",
        "Xpert\u00ae HemosIL\u00ae Factor II & Factor V Assay",
        "Xpert\u00ae HemosIL\u00ae Factor II & Factor V"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K082118",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033612",
        "K033607"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NPR",
        "NPQ",
        "OOI"
    ],
    "Summary Letter Date": "September 18, 2009",
    "Summary Letter Received Date": "August 7, 2009",
    "Submission Date": "August 6, 2009",
    "Regulation Number(s)": [
        "21 CFR 864.7280"
    ],
    "Regulation Name(s)": [
        "Factor V Leiden DNA mutation detection system",
        "Factor II Prothrombin and Factor V Leiden DNA Mutation Detection Systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor II (Prothrombin) G20210A",
        "Factor V (Leiden) G1691A"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "Sodium citrate tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert\u00ae Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification",
        "Real-time PCR",
        "Multiplex PCR",
        "Fluorescence detection",
        "Scorpion probes"
    ],
    "Methodologies": [
        "Genotyping",
        "Polymerase chain reaction (PCR)",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cartridge",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for Xpert HemosIL Factor II & Factor V Assay, a real-time PCR genotyping test for thrombophilia-associated mutations using the Cepheid GeneXpert Dx System.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic genotyping test for rapid detection of Factor II (G20210A) and Factor V (Leiden) mutations from sodium citrate or EDTA anticoagulated whole blood, aiding in the diagnosis of individuals with suspected thrombophilia.",
    "fda_folder": "Hematology"
}